Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XAIR Beyond Air, Inc.

Post-Mkt 05-08 16:03:19 EDT

0.5130

+0.0158

+3.18%

High0.5268	Low0.4801	Vol241.27K
Open0.4898	D1 Closing0.4972	Amplitude9.39%
Mkt Cap6.51M	Tradable Cap6.36M	Total Shares12.69M
T/O122.00K	T/O Rate1.94%	Tradable Shares12.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XAIR","market":"US","secType":"STK","nameCN":"Beyond Air, Inc.","latestPrice":0.513,"timestamp":1778270400000,"preClose":0.4972,"halted":0,"volume":241274,"delay":0,"changeRate":0.031777956556717696,"floatShares":12405100,"shares":12692700,"eps":-5.064474,"marketStatus":"Post-Mkt","change":0.0158,"latestTime":"05-08 16:03:19 EDT","open":0.4898,"high":0.5268,"low":0.4801,"amount":122000.261444,"amplitude":0.093926,"askPrice":0.5267,"askSize":100,"bidPrice":0.4573,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-5.064474,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1778284800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4972,"preHourTrading":{"tag":"盘前","latestPrice":0.489,"preClose":0.4972,"latestTime":"09:29 EDT","volume":1543,"amount":762.31464444,"timestamp":1778246999016,"change":-0.0082,"changeRate":-0.016492,"amplitude":0.042639},"volumeRatio":0.84367,"impliedVol":0.406,"impliedVolPercentile":0.3636},"requestUrl":"/m/hq/s/XAIR","defaultTab":"news","newsList":[{"id":"2628258137","title":"Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628258137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628258137?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:58","pubTimestamp":1776689920,"startTime":"0","endTime":"0","summary":"Beyond Cancer, a subsidiary of Beyond Air (XAIR), announced updated follow-up data from its Phase 1 UNO trial, which are being presented at the Ame...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-airs-beyond-cancer-reports-updated-data-from-phase-1-uno-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-airs-beyond-cancer-reports-updated-data-from-phase-1-uno-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740745","title":"Beyond Cancer posts updated Phase 1 UNO survival data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740745?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:06","pubTimestamp":1776686791,"startTime":"0","endTime":"0","summary":"Beyond Cancer, Beyond Air unit, reported updated Phase 1 follow-up for intratumoral UNO presented at AACR 2026.Six of 10 heavily pretreated patients were alive 22 to 40 months after a single UNO injection as of Feb. 2, 2026.Median overall survival was not reached at last follow-up because more than 50% of patients remained alive.Safety profile was generally favorable; one treatment-related serious adverse event, hypoxia, resolved fully.Beyond Cancer received a US Notice of Allowance for a patent covering gas delivery technology for UNO.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL8JJtTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2210149790.SGD","LU0314104364.USD","SG9999014039.USD","BK4082","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","SG9999014021.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","BK4588","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628406527","title":"Beyond Cancer Reports Updated Survival and Safety Data From Phase 1 Uno Trial Presented at Aacr 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628406527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628406527?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:00","pubTimestamp":1776686404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nTUA8D7DKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XAIR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627811002","title":"Beyond Air executives to attend D. Boral Capital Global Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627811002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627811002?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:03","pubTimestamp":1776254587,"startTime":"0","endTime":"0","summary":"Beyond Air will participate in D. Boral Capital Global Conference 2026 on May 7 at The Plaza Hotel in New York.CEO Robert Goodman will attend one-on-one meetings at the event.CFO Dan Moorhead will also take part in the one-on-one meeting format.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL6cYxhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4112","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014005.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4588","BK4082","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","BK4585","LU2210149790.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284189","title":"Beyond Air to Participate in the D. Boral Capital Global Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284189","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284189?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:00","pubTimestamp":1776254400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., April  15, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274357/0/en/Beyond-Air-to-Participate-in-the-D-Boral-Capital-Global-Conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626489331","title":"Beyond Air faces Nasdaq delisting after shares trade below $1 bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2626489331","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626489331?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:32","pubTimestamp":1775853139,"startTime":"0","endTime":"0","summary":"Beyond Air received Nasdaq notice April 7, 2026 for failing to meet $1 minimum bid price under Listing Rule 5550.Noncompliance was triggered by 30 consecutive business days below $1 from Feb. 23, 2026 to April 6, 2026.Nasdaq said Beyond Air is not eligible for standard 180-day cure period because it completed a 1-for-20 reverse split on July 14, 2025.Nasdaq warned shares face delisting unless Beyond Air requests a hearing by April 14, 2026; a timely request would stay delisting pending panel decision.Beyond Air is weighing steps to regain compliance, including another reverse stock split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via EDGAR, the Electro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL9xc4kS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624503541","title":"Beyond Air CEO Steve Lisi resigns; CCO Robert Goodman named CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2624503541","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624503541?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:32","pubTimestamp":1775075555,"startTime":"0","endTime":"0","summary":"Beyond Air CEO Steve Lisi resigned, stepping down from board effective March 27, 2026.Board appointed Chief Commercial Officer Robert Goodman as CEO, effective today.Goodman joined Beyond Air board in June 2025.He served as Chief Commercial Officer from November 2025 to March 2026.Goodman previously held leadership roles at BioTelemetry, Philips Healthcare, Thermo Fisher Scientific, Pfizer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL35vDDy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622291.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1894683264.USD","LU2298321311.HKD","LU2433249047.HKD","IE00B19Z8X17.USD","BK4121","LU2468319806.SGD","LU1064131342.USD","BK4535","LU0957791311.USD","LU2125909759.SGD","LU0225284248.USD","LU1291159041.SGD","LU2112291526.USD","LU2357305700.SGD","LU2125909247.SGD","SG9999002224.SGD","LU2764262908.HKD","GB00BDT5M118.USD","BK4581","BK4007","IE00BKPKM429.USD","LU2720916845.USD","BK4566","LU1720051108.HKD","LU2543165471.USD","SG9999011175.SGD","LU1066051498.USD","LU1670627923.USD","LU1023059063.AUD","LU1923622614.USD","LU0096362180.USD","LU1815333072.USD","LU0557290698.USD","LU0320765489.SGD","BK4599","SG9999001176.USD","LU0234572021.USD","LU0114720955.EUR","LU0170899867.USD","LU1854104046.USD","LU1883839398.USD","BK4548","LU2360108059.USD","IE0034235188.USD","XAIR","LU0456855351.SGD","LU1803068623.USD","BK4082","LU2764263039.SGD","LU0266013472.USD","IE00B19Z8W00.USD","IE000M9KFDE8.USD","BK4568","LU2211815571.USD","LU1720051017.SGD","LU2092937221.SGD","LU2041044095.USD","LU2125909916.SGD","LU1791710400.SGD","LU0345770308.USD","LU1548497426.USD","LU1066053197.SGD","LU1983299246.USD","BK4533","IE00BLSP4452.SGD","BK4592","BK4550","LU1712237335.SGD","IE00BBT3K403.USD","IE0002270589.USD","LU0058720904.USD","IE00B19Z9505.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2125910179.SGD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0070302665.USD","LU2125910336.SGD","LU0345770993.USD","BK4588","IE00B2B36J28.USD","SG9999002232.USD","LU0061474960.USD","IE00BQXX3C00.GBP","LU0985481810.HKD","LU0011850046.USD","LU2764263203.CNY","LU0225771236.USD","LU1061106388.HKD","LU1894683348.USD","BK4534","IE00B19Z3B42.SGD","LU0306806265.USD","LU0321505868.SGD","LU0882574055.USD","LU2264538146.SGD","LU2211814178.USD","LU0640476718.USD","BK4585","SG9999013999.USD","LU0342679015.USD","LU0122379950.USD","LU0289739699.SGD","LU1989771016.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU1854103824.USD","IE0002141913.USD","LU1280957306.USD","IE00BLSP4239.USD","LU1633808545.USD","SG9999003800.SGD","IE00BQXX3D17.EUR","LU0823416689.USD","LU2125909593.SGD","LU1153585028.USD","LU0316494557.USD","LU0528227936.USD","LU2089984988.USD","LU2063271972.USD","LU0321505439.SGD","LU1670628061.USD","LU0208291251.USD","LU1623119135.USD","LU1791710582.SGD","LU0306807586.USD","LU1988902786.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU1923621640.USD","IE0009355771.USD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624543201","title":"BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2624543201","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624543201?lang=en_us&edition=fundamental","pubTime":"2026-04-02 01:53","pubTimestamp":1775065980,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa BiosciencesWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nL6N40K0PA:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXYZ","WDC","OCGN","PWR","DE","HON","LEXX","FCX","MAXN","CBRE","ALKS","NCEL","PKG","BX","HMH","AVY","MMSI","DIS","RIVN","RILY","CAG","NKE","SCCO","ANIX","SATS","PM","LUNR","IMUX","HWM","ETN","RH","AGH","ZYME","JANX","INTC","NNOX","XAIR","CVX","NEM","STX","BYND","NCNO","O","AXSM","MU","TEX","MO","CYCN","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624516171","title":"Beyond Air Expands Commercial Access for Lungfit® Ph Through a Purchasing Agreement With a Top 3 National Group Purchasing Organization (Gpo)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624516171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624516171?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:00","pubTimestamp":1775048403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAW7FTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624516093","title":"Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624516093","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624516093?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:00","pubTimestamp":1775048400,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., April  01, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266697/0/en/Beyond-Air-Expands-Commercial-Access-for-LungFit-PH-Through-a-Purchasing-Agreement-with-a-Top-3-National-Group-Purchasing-Organization-GPO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","PH","XAIR","LU1064131342.USD","BK4161","LU0417517546.SGD","BK4082","LU0320765489.SGD","NHLD","LU0256863902.USD","BK4588","LU0208291251.USD","LU0211331839.USD","LU2264538146.SGD","LU1989772840.SGD","LU1989772923.USD","BK4580","LU0256863811.USD","LU1988902786.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622829054","title":"Beyond Air Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2622829054","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622829054?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:32","pubTimestamp":1774614720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XAIR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 08:32 ET (12:32 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823359","title":"BTIG Sticks to Its Hold Rating for Beyond Air (XAIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823359?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:59","pubTimestamp":1774609155,"startTime":"0","endTime":"0","summary":"BTIG analyst Marie Thibault maintained a Hold rating on Beyond Air yesterday. The company’s shares closed yesterday at $0.69. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-hold-rating-for-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-sticks-to-its-hold-rating-for-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893899","title":"Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622893899?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:10","pubTimestamp":1774555858,"startTime":"0","endTime":"0","summary":"Beyond Air (XAIR) announced that Steve Lisi has resigned as CEO and stepped down from the board of directors, effective March 27 to pursue other op...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-ceo-steve-lisi-resigns-robert-goodman-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-ceo-steve-lisi-resigns-robert-goodman-succeeds-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LSIIF","BK4082","BK4187","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622124896","title":"Press Release: Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2622124896","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622124896?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"GARDEN CITY, N.Y., March 26, 2026  -- Beyond Air, Inc.  , a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide  to improve the lives of patients, today announced that Steve Lisi has resigned as Chief Executive Officer and stepped down from the Board of Directors, effective March 27, 2026, to pursue other opportunities. The Board of Directors has appointed Robert Goodman, the Company's current Chief Commercial Officer and Director, as Chief Executive Officer, effective today.Mr. Goodman is a seasoned healthcare executive and board director with a distinguished track record of leadership across the medical technology and pharmaceutical industries. He joined the Board of Beyond Air in June 2025 and served as Chief Commercial Officer from November 2025 to March 2026 where he led a rapid transformation of the business strategy, grounded in technology, process and people, positioning the business for scalable and sustainable growth. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LSIIF","XAIR","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620255610","title":"Beyond Air Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2620255610","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620255610?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:34","pubTimestamp":1773837240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/XAIR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2026 08:34 ET (12:34 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XAIR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620576406","title":"Beyond Air Unit Reports Positive Safety Data From Phase 1 Intratumoral Nitric Oxide Monotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620576406","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620576406?lang=en_us&edition=fundamental","pubTime":"2026-03-18 05:57","pubTimestamp":1773784621,"startTime":"0","endTime":"0","summary":"Beyond Air  unit Beyond Cancer said its Phase 1 clinical trial evaluating a single intratumoral injection of ultra-high-concentration nitric oxide administered as monotherapy for cutaneous or subcutaneous primary or metastatic lesions showed a favorable safety and tolerability profile.Seven of the 10 patients in the study remained alive between 19 and 37 months after a single dose as of Oct. 1, 2025, the company said Tuesday in a statement.Most treatment-related adverse events were grade 1, with one serious adverse event of hypoxia that fully resolved, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAIR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620405882","title":"Beyond Air subsidiary reports signs of clinical activity from UNO trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2620405882","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620405882?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:45","pubTimestamp":1773780351,"startTime":"0","endTime":"0","summary":"Beyond Cancer, a subsidiary of Beyond Air (XAIR), announced early signs of clinical activity and a favorable safety and tolerability profile from i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-subsidiary-reports-signs-of-clinical-activity-from-uno-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-subsidiary-reports-signs-of-clinical-activity-from-uno-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620403549","title":"Beyond Cancer reports early clinical activity in Phase 1 UNO solid tumor trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2620403549","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620403549?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:35","pubTimestamp":1773779729,"startTime":"0","endTime":"0","summary":"Beyond Cancer, a subsidiary of Beyond Air, reported interim Phase 1 data from its UNO trial evaluating a single intratumoral injection of ultra-high concentration nitric oxide in 10 patients with unresectable cutaneous or subcutaneous tumors. As of Oct. 1, 2025, seven of 10 patients were alive 19 to 37 months after treatment, and one patient died from disease progression 25 months after treatment. Beyond Cancer said two patients with triple negative breast cancer had no evidence of disease, and no deaths occurred within 12 weeks after treatment. The company reported most treatment-related adverse events were Grade 1, and one treatment-related serious adverse event of hypoxia occurred during administration at 25,000 ppm and resolved fully. Beyond Cancer said the data are scheduled for presentation at AACR Annual Meeting 2026 on April 19, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbkgDkD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4082","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014005.SGD","XAIR","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","BK4112","IE00BN0W2T93.GBP","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620035924","title":"Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile With Interim Data From Phase 1 Uno Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2620035924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620035924?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:35","pubTimestamp":1773779700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA7QBRXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XAIR","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618978413","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618978413","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618978413?lang=en_us&edition=fundamental","pubTime":"2026-03-12 03:40","pubTimestamp":1773258006,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zevra Therapeutics (ZVRA – Research Report), Verrica Pharmaceutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-zevra-therapeutics-zvra-verrica-pharmaceuticals-vrca-and-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-zevra-therapeutics-zvra-verrica-pharmaceuticals-vrca-and-beyond-air-xair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","BK4585","HCSG","BK4007","LU0128526141.USD","BK4137","LU0029874061.USD","XLV","VRCA","BK4082","XAIR","ZVRA","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beyondair.net","stockEarnings":[{"period":"1week","weight":-0.0533},{"period":"1month","weight":-0.2997},{"period":"3month","weight":-0.5677},{"period":"6month","weight":-0.7175},{"period":"1year","weight":-0.8619},{"period":"ytd","weight":-0.3152}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.079389},{"month":2,"riseRate":0.571429,"avgChangeRate":0.031729},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.08312},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.158515},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.039715},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058187},{"month":7,"riseRate":0.5,"avgChangeRate":0.040624},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.051334},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.093473},{"month":10,"riseRate":0.428571,"avgChangeRate":0.021382},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.048124},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.099782}],"exchange":"NASDAQ","name":"Beyond Air, Inc.","nameEN":"Beyond Air, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beyond Air, Inc.(XAIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beyond Air, Inc.,XAIR,Beyond Air, Inc.股票,Beyond Air, Inc.股票老虎,Beyond Air, Inc.股票老虎国际,Beyond Air, Inc.行情,Beyond Air, Inc.股票行情,Beyond Air, Inc.股价,Beyond Air, Inc.股市,Beyond Air, Inc.股票价格,Beyond Air, Inc.股票交易,Beyond Air, Inc.股票购买,Beyond Air, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beyond Air, Inc.(XAIR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beyond Air, Inc.(XAIR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction